Literature DB >> 18368010

Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.

Panos G Georgopoulos1, Alan F Sasso, Sastry S Isukapalli, Paul J Lioy, Daniel A Vallero, Miles Okino, Larry Reiter.   

Abstract

A conceptual/computational framework for exposure reconstruction from biomarker data combined with auxiliary exposure-related data is presented, evaluated with example applications, and examined in the context of future needs and opportunities. This framework employs physiologically based toxicokinetic (PBTK) modeling in conjunction with numerical "inversion" techniques. To quantify the value of different types of exposure data "accompanying" biomarker data, a study was conducted focusing on reconstructing exposures to chlorpyrifos, from measurements of its metabolite levels in urine. The study employed biomarker data as well as supporting exposure-related information from the National Human Exposure Assessment Survey (NHEXAS), Maryland, while the MENTOR-3P system (Modeling ENvironment for TOtal Risk with Physiologically based Pharmacokinetic modeling for Populations) was used for PBTK modeling. Recently proposed, simple numerical reconstruction methods were applied in this study, in conjunction with PBTK models. Two types of reconstructions were studied using (a) just the available biomarker and supporting exposure data and (b) synthetic data developed via augmenting available observations. Reconstruction using only available data resulted in a wide range of variation in estimated exposures. Reconstruction using synthetic data facilitated evaluation of numerical inversion methods and characterization of the value of additional information, such as study-specific data that can be collected in conjunction with the biomarker data. Although the NHEXAS data set provides a significant amount of supporting exposure-related information, especially when compared to national studies such as the National Health and Nutrition Examination Survey (NHANES), this information is still not adequate for detailed reconstruction of exposures under several conditions, as demonstrated here. The analysis presented here provides a starting point for introducing improved designs for future biomonitoring studies, from the perspective of exposure reconstruction; identifies specific limitations in existing exposure reconstruction methods that can be applied to population biomarker data; and suggests potential approaches for addressing exposure reconstruction from such data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368010      PMCID: PMC3068528          DOI: 10.1038/jes.2008.9

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


  98 in total

1.  Efficient sensitivity/uncertainty analysis using the combined stochastic response surface method and automated differentiation: application to environmental and biological systems.

Authors:  S S Isukapalli; A Roy; P G Georgopoulos
Journal:  Risk Anal       Date:  2000-10       Impact factor: 4.000

2.  Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements.

Authors:  M L Rigas; M S Okino; J J Quackenboss
Journal:  Toxicol Sci       Date:  2001-06       Impact factor: 4.849

3.  Uses and issues of biomonitoring.

Authors:  Larry L Needham; Antonia M Calafat; Dana B Barr
Journal:  Int J Hyg Environ Health       Date:  2006-12-08       Impact factor: 5.840

4.  Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes.

Authors:  J Tang; Y Cao; R L Rose; A A Brimfield; D Dai; J A Goldstein; E Hodgson
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

5.  Extreme regression.

Authors:  Michael LeBlanc; James Moon; Charles Kooperberg
Journal:  Biostatistics       Date:  2005-06-22       Impact factor: 5.899

6.  Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model.

Authors:  C Timchalk; A Kousba; T S Poet
Journal:  Toxicol Lett       Date:  2002-09-05       Impact factor: 4.372

7.  Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home.

Authors:  Nancy K Wilson; Jane C Chuang; Christopher Lyu; Ronald Menton; Marsha K Morgan
Journal:  J Expo Anal Environ Epidemiol       Date:  2003-05

8.  Chlorpyrifos: pharmacokinetics in human volunteers.

Authors:  R J Nolan; D L Rick; N L Freshour; J H Saunders
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

Review 9.  Transport of toxic metals by molecular mimicry.

Authors:  Nazzareno Ballatori
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

10.  Analysis of aggregate exposure to chlorpyrifos in the NHEXAS-Maryland investigation.

Authors:  Yaohong Pang; David L MacIntosh; David E Camann; P Barry Ryan
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031

View more
  19 in total

1.  Exposure science and its places in environmental health sciences and risk assessment: why is its application still an ongoing struggle in 2014?

Authors:  Paul J Lioy
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01       Impact factor: 5.563

2.  Modeling Population Exposures to Silver Nanoparticles Present in Consumer Products.

Authors:  Steven G Royce; Dwaipayan Mukherjee; Ting Cai; Shu S Xu; Jocelyn A Alexander; Zhongyuan Mi; Leonardo Calderon; Gediminas Mainelis; KiBum Lee; Paul J Lioy; Teresa D Tetley; Kian Fan Chung; Junfeng Zhang; Panos G Georgopoulos
Journal:  J Nanopart Res       Date:  2014-11       Impact factor: 2.253

3.  Consensus Modeling of Median Chemical Intake for the U.S. Population Based on Predictions of Exposure Pathways.

Authors:  Caroline L Ring; Jon A Arnot; Deborah H Bennett; Peter P Egeghy; Peter Fantke; Lei Huang; Kristin K Isaacs; Olivier Jolliet; Katherine A Phillips; Paul S Price; Hyeong-Moo Shin; John N Westgate; R Woodrow Setzer; John F Wambaugh
Journal:  Environ Sci Technol       Date:  2018-12-24       Impact factor: 9.028

4.  Estimating Methylmercury Intake for the General Population of South Korea Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Seungho Lee; Yu-Mei Tan; Martin B Phillips; Jon R Sobus; Sungkyoon Kim
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

5.  A unified multiscale field/network/agent based modeling framework for human and ecological health risk analysis.

Authors:  Panos G Georgopoulos; Sastry S Isukapalli
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

6.  A tiered framework for risk-relevant characterization and ranking of chemical exposures: applications to the National Children's Study (NCS).

Authors:  Panos G Georgopoulos; Christopher J Brinkerhoff; Sastry Isukapalli; Michael Dellarco; Philip J Landrigan; Paul J Lioy
Journal:  Risk Anal       Date:  2014-01-27       Impact factor: 4.000

Review 7.  Exposure science: a view of the past and milestones for the future.

Authors:  Paul J Lioy
Journal:  Environ Health Perspect       Date:  2010-03-22       Impact factor: 9.031

8.  ebTrack: an environmental bioinformatics system built upon ArrayTrack.

Authors:  Minjun Chen; Jackson Martin; Hong Fang; Sastry Isukapalli; Panos G Georgopoulos; William J Welsh; Weida Tong
Journal:  BMC Proc       Date:  2009-03-10

Review 9.  Using national and local extant data to characterize environmental exposures in the national children's study: Queens County, New York.

Authors:  Paul J Lioy; Sastry S Isukapalli; Leonardo Trasande; Lorna Thorpe; Michael Dellarco; Clifford Weisel; Panos G Georgopoulos; Christopher Yung; Shahnaz Alimokhtari; Margot Brown; Philip J Landrigan
Journal:  Environ Health Perspect       Date:  2009-06-15       Impact factor: 9.031

10.  Exposure as part of a systems approach for assessing risk.

Authors:  Linda S Sheldon; Elaine A Cohen Hubal
Journal:  Environ Health Perspect       Date:  2009-04-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.